With state-of-the-art technology platforms of next-generation sequencing, long-read sequencing, microarray, and mass spectrometry, CD Genomics provides reliable services to pharmaceutical and biotechnology companies, academia and government agencies, and enjoys a high reputation. Our reputation is built on a legacy of delivering reliable services that meet and exceed our clients' expectations across more than 50 countries and districts. We are dedicated to offering the best and most professional service, consistently striving to raise the bar in genomics research.
CD Genomics – RNA Solutions is poised to revolutionize the study of RNA, targeting both coding and non-coding RNAs with diverse physiological functions. Our team of dedicated scientists is ready to assist you in uncovering the intricacies of various RNA types through meticulous and integrative approaches. CD Genomics has invested heavily in cutting-edge mainstream NGS, long-read sequencing, microarray analysis, and other platforms. This commitment to innovation allows us to offer you unmatched capabilities and insights into genomics research. This wealth of knowledge empowers us to assist you to uncover previously undetected changes that occur in disease states, responses to therapeutics, and variations under different environmental conditions, among many other applications.
To be the most trusted partner with pharmaceutical and biotechnology companies as well as academia and government agencies for RNA Sequencing, as well as integrated solutions that allow customers to comprehensively study coding and non-coding RNA of interest.
Submit high quality, high accuracy report on RNA and pathway analysis. To be the most trusted partner with pharmaceutical and biotechnology companies as well as academia and government agencies for RNA Sequencing and downstream bioinformatics analysis.
Flexibility for EFFECTIVE and Efficient Execution
Seamless Integration from Samples to Reports
Our dedication to RNA sequencing excellence has garnered the trust of industry leaders and esteemed research institutions. We cherish these partnerships and are privileged to share in their commitment to advancing science.